Parkinson
Entity.
- Evidence
- 118 documents · 55 separate publishers
- Standing
- A name from our starting list; its record is kept up to date automatically from coverage
- Time
- first seen 16 May 2026, last seen 7 Oct 2026
- Measured
- 33% of mentions say something specific about it; the rest only name it
- As of
- 8 Oct 2026
Where this comes from
- Clinical Trials Arena · 2026-10-07 · Parkinson’s disease market expected to reach $7.2bn across the 7MM by 2033 (opens the source in a new tab)
- Endpoints News · 2026-10-06 · Roche enlists Alector in Parkinson's deal, paying $100M upfront (opens the source in a new tab)
- The Medical News · 2026-10-06 · Managing misfolded proteins to prevent Parkinson’s disease (opens the source in a new tab)
- The Clinical Trial Vanguard · 2026-10-06 · Lundbeck’s Lu AF28996 gains 2+ hours daily ON-time in Parkinson’s Phase Ib (opens the source in a new tab)
- CBS News · 2026-10-04 · Alan Alda on fighting Parkinson's with laughter (opens the source in a new tab)
- BBC News · 2026-10-01 · Son who used AI to help save mum's life hopes case unlocks clues for other Parkinson's patients (opens the source in a new tab)
- STAT News · 2026-09-29 · STAT+: AbbVie wins FDA nod for Parkinson’s pill (opens the source in a new tab)
- European Medical Journal · 2026-09-29 · AbbVie wins FDA nod for Parkinson’s disease drug (opens the source in a new tab)
- Daily Sabah economy · 2026-09-28 · More REM sleep may lower risk of Parkinson’s, dementia: Study (opens the source in a new tab)
- Medical Daily · 2026-09-28 · AbbVie's Once-Daily Parkinson's Pill Juvmo Wins FDA Approval, with Nausea, Dizziness, and Headache Common in Trials (opens the source in a new tab)